Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum

Detalhes bibliográficos
Autor(a) principal: Castilho, A. C. S.
Data de Publicação: 2019
Outros Autores: Dalanezi, F. M. [UNESP], Franchi, F. F. [UNESP], Price, C. A., Ferreira, J. C. P. [UNESP], Trevisol, E. [UNESP], Buratini, J. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.theriogenology.2018.09.024
http://hdl.handle.net/11449/185323
Resumo: The aim of this study was to determine the expression of fibroblast growth factor 22 (FGF22) in the bovine corpus luteum (CL) and to investigate the effects of in vivo total or partial cloprostenol-induced luteolysis on the mRNA abundance of FGF22 and its receptor, FGFR1B. Corpora lutea at different stages of development were then dissected from abattoir ovaries (n = 10/stage); a portion of the tissue samples was fixed in paraformaldehyde and the remaining samples were homogenized and subjected to total RNA extraction. To assess mRNA abundance of target genes during induced luteolysis, nineteen cows were synchronized and then randomly assigned to a Latin square design as follows: Control; 2 administrations of prostaglandin F-2 alpha (PGF(2 alpha), total luteolysis; 2 x 250 mu g of cloprostenol sodium) and 1/6PGF(2 alpha) (partial luteolysis; 83.33 mu g of cloprostenol sodium). FGF22 and FGFR1B expression levels were measured by RT-qPCR, and FGF22 protein expression was detected by immunohistochemistry. In summary, FGF22 mRNA was detected at all stages of CL development, and FGF22 protein was also detected in luteal tissue. FGF22 mRNA expression was lower at stage IV than at stage III (P < 0.05), and the same pattern was observed in luteal immunoreactivity. Furthermore, cloprostenol-induced luteolysis, both total and partial, increased FGFR1B mRNA abundance in luteal tissue (P < 0.05), but did not affect FGF22 mRNA abundance. In conclusion, these data suggest a potential role for the FGF22-FGFR1B system during development and regression of bovine CL. (C) 2018 Elsevier Inc. All rights reserved.
id UNSP_c2935b578bd9f74acbda9a76b6941ca8
oai_identifier_str oai:repositorio.unesp.br:11449/185323
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteumCorpora luteaLuteal developmentFGF7 subfamilyCattleThe aim of this study was to determine the expression of fibroblast growth factor 22 (FGF22) in the bovine corpus luteum (CL) and to investigate the effects of in vivo total or partial cloprostenol-induced luteolysis on the mRNA abundance of FGF22 and its receptor, FGFR1B. Corpora lutea at different stages of development were then dissected from abattoir ovaries (n = 10/stage); a portion of the tissue samples was fixed in paraformaldehyde and the remaining samples were homogenized and subjected to total RNA extraction. To assess mRNA abundance of target genes during induced luteolysis, nineteen cows were synchronized and then randomly assigned to a Latin square design as follows: Control; 2 administrations of prostaglandin F-2 alpha (PGF(2 alpha), total luteolysis; 2 x 250 mu g of cloprostenol sodium) and 1/6PGF(2 alpha) (partial luteolysis; 83.33 mu g of cloprostenol sodium). FGF22 and FGFR1B expression levels were measured by RT-qPCR, and FGF22 protein expression was detected by immunohistochemistry. In summary, FGF22 mRNA was detected at all stages of CL development, and FGF22 protein was also detected in luteal tissue. FGF22 mRNA expression was lower at stage IV than at stage III (P < 0.05), and the same pattern was observed in luteal immunoreactivity. Furthermore, cloprostenol-induced luteolysis, both total and partial, increased FGFR1B mRNA abundance in luteal tissue (P < 0.05), but did not affect FGF22 mRNA abundance. In conclusion, these data suggest a potential role for the FGF22-FGFR1B system during development and regression of bovine CL. (C) 2018 Elsevier Inc. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Natural Sciences and Engineering Research Council of Canada (NSERC)Univ Oeste Paulista, Campus 2, BR-19067175 Presidente Prudente, SP, BrazilUniv Estadual Paulista, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Botucatu, SP, BrazilUniv Estadual Paulista, Inst Biociencias, Dept Farmacol, Botucatu, SP, BrazilUniv Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ, CanadaUniv Estadual Paulista, Inst Biociencias, Dept Fisiol, Botucatu, SP, BrazilUniv Estadual Paulista, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Botucatu, SP, BrazilUniv Estadual Paulista, Inst Biociencias, Dept Farmacol, Botucatu, SP, BrazilUniv Estadual Paulista, Inst Biociencias, Dept Fisiol, Botucatu, SP, BrazilElsevier B.V.Univ Oeste PaulistaUniversidade Estadual Paulista (Unesp)Univ MontrealCastilho, A. C. S.Dalanezi, F. M. [UNESP]Franchi, F. F. [UNESP]Price, C. A.Ferreira, J. C. P. [UNESP]Trevisol, E. [UNESP]Buratini, J. [UNESP]2019-10-04T12:34:27Z2019-10-04T12:34:27Z2019-02-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1-5http://dx.doi.org/10.1016/j.theriogenology.2018.09.024Theriogenology. New York: Elsevier Science Inc, v. 125, p. 1-5, 2019.0093-691Xhttp://hdl.handle.net/11449/18532310.1016/j.theriogenology.2018.09.024WOS:000455972500001Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengTheriogenologyinfo:eu-repo/semantics/openAccess2024-10-09T19:28:47Zoai:repositorio.unesp.br:11449/185323Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-10-09T19:28:47Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
title Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
spellingShingle Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
Castilho, A. C. S.
Corpora lutea
Luteal development
FGF7 subfamily
Cattle
title_short Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
title_full Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
title_fullStr Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
title_full_unstemmed Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
title_sort Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
author Castilho, A. C. S.
author_facet Castilho, A. C. S.
Dalanezi, F. M. [UNESP]
Franchi, F. F. [UNESP]
Price, C. A.
Ferreira, J. C. P. [UNESP]
Trevisol, E. [UNESP]
Buratini, J. [UNESP]
author_role author
author2 Dalanezi, F. M. [UNESP]
Franchi, F. F. [UNESP]
Price, C. A.
Ferreira, J. C. P. [UNESP]
Trevisol, E. [UNESP]
Buratini, J. [UNESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Oeste Paulista
Universidade Estadual Paulista (Unesp)
Univ Montreal
dc.contributor.author.fl_str_mv Castilho, A. C. S.
Dalanezi, F. M. [UNESP]
Franchi, F. F. [UNESP]
Price, C. A.
Ferreira, J. C. P. [UNESP]
Trevisol, E. [UNESP]
Buratini, J. [UNESP]
dc.subject.por.fl_str_mv Corpora lutea
Luteal development
FGF7 subfamily
Cattle
topic Corpora lutea
Luteal development
FGF7 subfamily
Cattle
description The aim of this study was to determine the expression of fibroblast growth factor 22 (FGF22) in the bovine corpus luteum (CL) and to investigate the effects of in vivo total or partial cloprostenol-induced luteolysis on the mRNA abundance of FGF22 and its receptor, FGFR1B. Corpora lutea at different stages of development were then dissected from abattoir ovaries (n = 10/stage); a portion of the tissue samples was fixed in paraformaldehyde and the remaining samples were homogenized and subjected to total RNA extraction. To assess mRNA abundance of target genes during induced luteolysis, nineteen cows were synchronized and then randomly assigned to a Latin square design as follows: Control; 2 administrations of prostaglandin F-2 alpha (PGF(2 alpha), total luteolysis; 2 x 250 mu g of cloprostenol sodium) and 1/6PGF(2 alpha) (partial luteolysis; 83.33 mu g of cloprostenol sodium). FGF22 and FGFR1B expression levels were measured by RT-qPCR, and FGF22 protein expression was detected by immunohistochemistry. In summary, FGF22 mRNA was detected at all stages of CL development, and FGF22 protein was also detected in luteal tissue. FGF22 mRNA expression was lower at stage IV than at stage III (P < 0.05), and the same pattern was observed in luteal immunoreactivity. Furthermore, cloprostenol-induced luteolysis, both total and partial, increased FGFR1B mRNA abundance in luteal tissue (P < 0.05), but did not affect FGF22 mRNA abundance. In conclusion, these data suggest a potential role for the FGF22-FGFR1B system during development and regression of bovine CL. (C) 2018 Elsevier Inc. All rights reserved.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-04T12:34:27Z
2019-10-04T12:34:27Z
2019-02-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.theriogenology.2018.09.024
Theriogenology. New York: Elsevier Science Inc, v. 125, p. 1-5, 2019.
0093-691X
http://hdl.handle.net/11449/185323
10.1016/j.theriogenology.2018.09.024
WOS:000455972500001
url http://dx.doi.org/10.1016/j.theriogenology.2018.09.024
http://hdl.handle.net/11449/185323
identifier_str_mv Theriogenology. New York: Elsevier Science Inc, v. 125, p. 1-5, 2019.
0093-691X
10.1016/j.theriogenology.2018.09.024
WOS:000455972500001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Theriogenology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1-5
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1834483396009525248